Purpose: To compare the similarity of answers provided by Generative Pretrained Transformer-4 (GPT-4) with those of a consensus statement on diagnosis, nonoperative management, and Bankart repair in anterior shoulder instability (ASI).
Methods: An expert consensus statement on ASI published by Hurley et al. in 2022 was reviewed and questions laid out to the expert panel were extracted. GPT-4, the subscription version of ChatGPT, was queried using the same set of questions. Answers provided by GPT-4 were compared with those of the expert panel and subjectively rated for similarity by 2 experienced shoulder surgeons. GPT-4 was then used to rate the similarity of its own responses to the consensus statement, classifying them as low, medium, or high. Rates of similarity as classified by the shoulder surgeons and GPT-4 were then compared and interobserver reliability calculated using weighted κ scores.
Results: The degree of similarity between responses of GPT-4 and the ASI consensus statement, as defined by shoulder surgeons, was high in 25.8%, medium in 45.2%, and low 29% of questions. GPT-4 assessed similarity as high in 48.3%, medium in 41.9%, and low 9.7% of questions. Surgeons and GPT-4 reached consensus on the classification of 18 questions (58.1%) and disagreement on 13 questions (41.9%).
Conclusions: The responses generated by artificial intelligence exhibit limited correlation with an expert statement on the diagnosis and treatment of ASI.
Clinical Relevance: As the use of artificial intelligence becomes more prevalent, it is important to understand how closely information resembles content produced by human authors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11240044 | PMC |
http://dx.doi.org/10.1016/j.asmr.2024.100923 | DOI Listing |
JAMA Otolaryngol Head Neck Surg
January 2025
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Importance: Airway stenosis is a rare but debilitating disorder that significantly degrades the quality of life in affected patients. Treatments are primarily surgical, and disease management lacks established medical therapies. The North American Airway Collaborative held its third symposium at The Johns Hopkins Hospital in Baltimore, Maryland, on April 15, 2024, focused on strategies to advance the care of these patients.
View Article and Find Full Text PDFBr J Dermatol
January 2025
Department of Dermatology, Yale University, New Haven, CT, USA.
Background: Generalised pustular psoriasis (GPP) is a chronic, systemic, neutrophilic inflammatory disease. A previous Delphi panel established areas of consensus on GPP, although patient perspectives were not included, and aspects of treatment goals remain unclear.
Objectives: To identify and achieve consensus on refined, specific treatment goals for GPP treatment via a Delphi panel with patient participation.
Int Endod J
January 2025
Centre for Oral, Clinical & Translational Sciences, King's College London, London, UK.
This position statement is a consensus view of an expert committee convened by the European Society of Endodontology (ESE). The statement is based on current clinical and scientific evidence as well as the collective reflective practice of the committee. The aim is to provide clinicians with evidence-based, authoritative information on the aetiology, clinical presentation, and management of cracks and fractures that typically manifest along the long axis of the crown and/or root.
View Article and Find Full Text PDFClin Mol Hepatol
January 2025
Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Wuhan, China.
As new evidence emerges, treatment strategies toward the functional cure of chronic hepatitis B are evolving. In 2019, a panel of national hepatologists published a Consensus Statement on the functional cure of chronic hepatitis B. Currently, an international group of hepatologists has been assembled to evaluate research since the publication of the original consensus, and to collaboratively develop the updated statements.
View Article and Find Full Text PDFAliment Pharmacol Ther
January 2025
Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Background: Brain-gut behaviour therapies (BGBT) have gained widespread acceptance as therapeutic modalities for the management of disorders of gut-brain interaction (DGBI). However, existing treatment evaluation methods in the medical field fail to capture the specific elements of scientific rigour unique to behavioural trial evaluation.
Aims: To offer the first consensus on the development and testing of BGBT in DGBI.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!